OSR Health, Inc. (OSRH)
OTCMKTS · Delayed Price · Currency is USD
0.1700
+0.0025 (1.49%)
At close: Aug 27, 2026
OSR Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 1.5 | 1.7 | 0.34 | 0.02 |
Cash & Short-Term Investments | 1.5 | 1.7 | 0.34 | 0.02 |
Cash Growth | -5.35% | 397.82% | 2115.08% | - |
Accounts Receivable | 0.19 | 0.32 | 0.9 | - |
Other Receivables | 0.06 | 0.07 | 0.03 | - |
Receivables | 0.35 | 0.39 | 0.93 | - |
Inventory | 0.59 | 0.2 | 0.92 | - |
Prepaid Expenses | 0.37 | - | - | 0.01 |
Other Current Assets | 0.05 | 0.53 | 0.13 | - |
Total Current Assets | 2.87 | 2.82 | 2.33 | 0.02 |
Property, Plant & Equipment | 0.18 | 0.23 | 0.08 | - |
Goodwill | 29.19 | 24.95 | 24.35 | - |
Other Intangible Assets | 134.14 | 142.46 | 148.06 | - |
Long-Term Deferred Tax Assets | 0.19 | 0.2 | 0.09 | - |
Other Long-Term Assets | 0.03 | 0.02 | 0.02 | 36.61 |
Total Assets | 166.62 | 171.24 | 175.24 | 36.63 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accounts Payable | 8.01 | 7.83 | 1.08 | 1.08 |
Accrued Expenses | 1.09 | 0.96 | 0.46 | 0.36 |
Short-Term Debt | 4.88 | 4.34 | 1.8 | 0.07 |
Current Portion of Leases | 0.03 | 0.05 | 0.04 | - |
Current Income Taxes Payable | 0.49 | 0.49 | 0 | 0.52 |
Other Current Liabilities | 0.97 | 3.5 | 0.08 | - |
Total Current Liabilities | 15.73 | 17.17 | 3.46 | 2.04 |
Long-Term Debt | 0.27 | - | 0.5 | - |
Long-Term Leases | 0 | 0.01 | 0.03 | - |
Long-Term Deferred Tax Liabilities | 25.64 | 27.02 | 28.04 | - |
Other Long-Term Liabilities | 0.07 | 0 | 0 | 38.5 |
Total Liabilities | 41.71 | 44.2 | 32.03 | 40.53 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 147.29 | 110.97 | 162.61 | - |
Retained Earnings | -40.95 | -37.17 | -19.17 | -3.91 |
Comprehensive Income & Other | -2.08 | 3.84 | -0.23 | - |
Total Common Equity | 104.27 | 77.64 | 143.21 | -3.91 |
Minority Interest | 20.64 | 49.4 | - | - |
Shareholders' Equity | 124.91 | 127.04 | 143.21 | -3.91 |
Total Liabilities & Equity | 166.62 | 171.24 | 175.24 | 36.63 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 5.46 | 4.4 | 2.38 | 0.07 |
Net Cash (Debt) | -3.96 | -2.7 | -2.03 | -0.06 |
Net Cash Growth | - | - | - | - |
Net Cash Per Share | -0.14 | -0.14 | -0.94 | - |
Filing Date Shares Outstanding | 35.12 | 33.12 | 19.28 | - |
Total Common Shares Outstanding | 35.12 | 26.6 | 2.32 | - |
Working Capital | -12.87 | -14.35 | -1.14 | -2.02 |
Book Value Per Share | 2.97 | 2.92 | 61.73 | - |
Tangible Book Value | -59.06 | -89.78 | -29.2 | -3.91 |
Tangible Book Value Per Share | -1.68 | -3.38 | -12.59 | - |
Machinery | 0.12 | 0.09 | 0.08 | - |